Risk of Heart Failure Hospitalization for GLP-1 Receptor Agonists Versus DPP-4 Inhibitors or SGLT-2 Inhibitors in Patients With Type 2 Diabetes: A Target Trial Emulation

20260 citationsJournal Article

Authors

Yan Xu · Peking University

Tao Huang · Peking University

Yue Zhang · Peking University

Dongze Ji · Peking University

Katherine R. Tuttle · Providence Regional Medical Center Everett

Juan-Jesus Carrero · Danderyds sjukhus

Edouard L Fu ·

Abstract

GLP-1RA use is associated with a lower risk of HHF compared with DPP-4i and similar risks compared with SGLT-2i in routine clinical care for patients with type 2 diabetes.

Topics & Keywords

Diabetes Treatment and Management Heart Failure Treatment and Management Bariatric Surgery and Outcomes

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Circulation

DOI: 10.1161/circulationaha.125.075157

Field-Weighted Citation Impact: 0.00